Systemic sclerosis, silica exposure and cellular therapies: The sand in the gears? von Lescoat, A., Rimar, D., Farge, D.

Volltext

FRI0244 Lysyl Oxidase as A Biomarker in Systemic Sclerosis– A Multicenter Study von Rimar, D., Balbir Gurman, A., Meroni, P., Farge, D., Levy, Y., Rosner, I., Slobodin, G., Jiries, N., Rozenbaum, M., Kaly, L., Boulman, N., Zilber, K., Ginsberg, S., Awisat, A., Vadasz, Z.

Volltext

AB0931 Anti-TNF Agents in Intractable Familial Mediterranean Fever with Axial Spondylarthropathy: Four Cases von Rozenbaum, M., Kaly, L., Rimar, D., Slobodin, G., Boulman, N., Jiries, N., Rosner, I.

Volltext

AB0967 Determinants of Aortic Wall Thickness in Patients without Aortitis: A Computed Tomography-Based Study von Nakhleh, A., Rimar, D., Rukhkyan, I., Wolfson, V., Rosner, I., Odeh, M., Slobodin, G.

Volltext

AB0539 Tofacitinib for Polyarteritis Nodosa – A Tailored Therapy von Rimar, D., Alpert, A., Starosvetsky, E., Rosner, I., Slobodin, G., Rozenbaum, M., Kaly, L., Boulman, N., Awisat, A., Shen Orr, S.S.

Volltext

AB0195 Semaphorin 3A as A Possible Immunoregulator in Systemic Sclerosis von Rimar, D., Rosner, I., Slobodin, G., Boulman, N., Rozenbaum, M., Halasz, K., Haj, T., Jiries, N., Kaly, L., Vadasz, Z.

Volltext

Indications for a “Surgery-First” Approach for the Treatment of Lower Extremity Arterial Disease von Kumar, Mohineesh, Long, Graham W., Rimar, Steven D., Studzinski, Diane M., Callahan, Rose E., Brown, O. William

Volltext

Vaccination SARS-CoV-2 chez les patients atteints de sclérodermie systémique et traités par autogreffe de cellules souches hématopoïétiques, au nom du Groupe MATHEC-SFGM-TC von Biard, L., Pugnet, G., Cacciatore, C., Munia, I., Lansiaux, P., Le Maignan, C., Crichi, B., Urbain, F., Marjanovic, Z., Berthier, S., Rimar, D., Farge, D.

Volltext

AB0141 Lysyl oxidase is correlated with fibrosis in systemic sclerosis von Rimar, D., Rosner, I., Slobodin, G., Rozenbaum, M., haj, T., Jiries, N., Kaly, L., Boulman, N., Vadas, Z.

Volltext

Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment von Smolyakov, R, Borer, A, Riesenberg, K, Schlaeffer, F, Alkan, M, Porath, A, Rimar, D, Almog, Y, Gilad, J

Volltext

Semaphorin 3A, a potential immune regulator in Familial Mediterranean Fever von Rimar, D, Rosner, I, Slobodin, G, Boulman, N, Kaly, L, Rozenbaum, M, Vadasz, Z

Volltext

Variant CAPS in an adult- the use of genetics von Rozenbam, M, Rimar, D, Kaly, L, Slobodin, G, Awisat, A, Rosner, I

Volltext

Anti-tumor necrosis factor treatment and pregnancy: the way is open von Boulman, N, Rimar, D, Rozenbaum, M, Slobodin, G, Younis, S, Rosner, I

Volltext

Rheumatology Education in Europe: results of a survey of young rheumatologists von BANDINELLI, F, BIJLSMA, J. W. J, MAYER, M, DUARTE MARQUES, C. C, DA SILVA, J. A. P, CUTOLO, M, RAMIRO, M. S, ELFVING, P, GOEKOOP-RUITERMAN, Y. P. M, SIVERA, F, MOLTO REVILLA, A, MARINESCU, C, RIMAR, D, NORKUVIENE, E

Volltext

The role of regulatory T cells in familial Mediterranean fever (FMF) von Rimar, D., Rosner, I., Slobodin, G., Boulman, N., Toubi, E., Kessel, A., Peri, R., Rozenbaum, M.

Volltext

1039 IS FAMILIAL MEDITERRANEAN FEVER (FMF) ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)? von Rimar, D, Rosner, I, Rozenbaum, M, Zuckerman, E

Volltext

Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis von Allanore, Yannick, Riemekasten, Gabriela, Vettori, Serena, Matucci‐Cerinic, Marco, Launay, David, Walker, Ulrich, Lapadula, Giovanni, Sierakowsky, Stanislaw, Siegert, Elise, Nicoara, Ileana, Kahan, André, Carreira, Patricia E., Novak, Srdan, Varju, Cecilia, Chizzolini, Carlo, Widuchowska, Malgorzata, Rozman, Blaz, Mallia, Carmel, Wu, Chen, Hij, Darin, Dhamadi, Roza, Wollheim, Frank, Wuttge, Dirk M., Andréasson, Kristofer, Martinovic, Duska, Balbir‐Gurman, Alexandra, Braun‐Moscovici, Yolanda, Lo Monaco, Andrea, Caramaschi, Paola, Henes, Jörg, Santamaria, Vera Ortiz, Heitmann, Stefan, Krasowska, Dorota, Himsel, Andrea, Da Silva, José Antonio Pereira, Stamenkovic, Bojana, Tikly, Mohammed, Tarner, Ingo, Damgaard, Kirsten, Mendoza, Antonio Zea, Sifuentes Giraldo, WA, Midtvedt, Øyvind, Riccieri, Valeria, Ionescu, Ruxandra Maria, Opris, Daniela, Groseanu, Laura, Cornateanu, Roxana Sfrent, Ionitescu, Razvan, Gherghe, Ana Maria, Gorga, Marilena, Bojinca, Mihai, Distler, Jörg H. W., Beyer, Christian, Meroni, Pierluigi, Ingegnoli, Francesca, Mouthon, Luc, De Keyser, Filip, Smith, Vanessa, Corrado, Ada, Pozzi, Maria R., Eyerich, Kilian, Knott, Elisabeth, Wiland, Piotr, Szmyrka‐Kaczmarek, Magdalena, Morgiel, Ewa, Krummel‐Lorenz, Brigitte, Günther, Claudia, Souza Müller, Carolina, Azevedo, Valderílio F., Groppa, Liliana, Chiaburu, Lealea, Russu, Eugen, Zenone, Thierry, Stebbings, Simon, Highton, John, Stamp, Lisa, Solanki, Kamal, Doube, Alan, Loyo, Esthela, Li, Mengtao, Rosato, Edoardo, Amoroso, Antonio, Tanaseanu, Cristina‐Mihaela, Dumitrascu, Alina, Foti, Rosario, Chirieac, Rodica, Ancuta, Codrina, Villiger, Peter, Adler, Sabine, Rubio, Silvia Rodriguez, Exposito, Marta Valero, Chatelus, Emmanuel, Chifflot, Hélène, Butrimiene, Irena, Rugiene, Rita, Karpec, Diana, Montoya, Fabiana, Limonta, Massimiliano, Brucato, Antonio Luca, Spertini, François

Volltext

A6.14Semaphorin 3A, an immunoregulator and potential biomarker for disease severity in systemic sclerosis von Vadasz, Z, Rimar, D, Toubi, E

Volltext

A6.14 Semaphorin 3A, an immunoregulator and potential biomarker for disease severity in systemic sclerosis von Vadasz, Z, Rimar, D, Toubi, E

Volltext

Improved prognosis of patients presenting with clinical markers of spontaneous reperfusion during acute myocardial infarction von Rimar, D, Crystal, E, Battler, A, Gottlieb, S, Freimark, D, Hod, H, Boyko, V, Mandelzweig, L, Behar, S, Leor, J

Volltext